Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.404 5-Year IF: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Volume 40, 2020 Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v23.i3.20
52 pages

Proteoglycan-Induced Arthritis: Immune Regulation, Cellular Mechanisms, and Genetics

Tibor T. Glant
Section of Biochemistry and Molecular Biology, Dept.of Orthopedic Surgery,1735 W.Harrison St.,Cohn Research Building, Suite 708, Rush University at Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL 60612
Alison Finnegan
Section of Biochemistry and Molecular Biology, and Departments of Internal Medicine (Section of Rheumatology) and Immunology/Microbiology, Rush University at Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL 60612
Katalin Mikecz
Section of Biochemistry and Molecular Biology,Departments of Biochemistry and Orthopedic Surgery, and Immunology/Microbiology, Rush University at Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL 60612


Rheumatoid arthritis is probably the least understood systemic autoimmune disease, and it affects approximately 1% of the human population. Several lines of evidence indicate that the effector mechanism, which initially attacks small joints, is T-cell driven. As a result, an aggressive synovial pannus develops, which destroys articular cartilage and bone, leading to massive ankylosis and deformities of peripheral joints. The disease has a progressive character, with the involvement of more and more joints. Although the target organ is the synovial joint, there is no clear evidence that any macromolecule of cartilaginous tissues, bone, or synovium, could be a preferential autoantigen. There are numerous rodent models that simulate some or many of the clinical, immunological, or histopathological features of the disease. Recently, it has become a strong working hypothesis that MHC and non-MHC genetic components share loci that are common in various autoimmune diseases, and in corresponding animal models. The most relevant animal models of rheumatoid arthritis appear to be those induced by cartilage matrix components such as type II collagen or proteoglycan aggrecan. This review summarizes our current knowledge of cartilage proteoglycan (aggrecan)-induced arthritis in mice.

Articles with similar content:

Non-Major Histocompatibility Complex Rheumatoid Arthritis Susceptibility Genes
Critical Reviews™ in Immunology, Vol.31, 2011, issue 2
Saleh M. Ibrahim, Manfred Kunz
Autoantigens and Immune Pathways in Rheumatoid Arthritis
Critical Reviews™ in Immunology, Vol.22, 2002, issue 4
Gabriel S. Panayi, Valerie M. Corrigall
Biomaterials, Fibrosis, and the Use of Drug Delivery Systems in Future Antifibrotic Strategies
Critical Reviews™ in Biomedical Engineering, Vol.37, 2009, issue 3
Ryan J. Love, Kim S. Jones
MHC Genes Linked to Autoimmune Disease
Critical Reviews™ in Immunology, Vol.35, 2015, issue 3
Philip Deitiker, M. Zouhair Atassi
Genome-Wide Association Studies and Infectious Disease
Critical Reviews™ in Immunology, Vol.30, 2010, issue 3
Anne M. Bowcock